|   |   | 
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/605 | |
| A61K 38/26 | 
| (11) | Number of the document | 3551652 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 17832481.0 | 
| Date of filing the European patent application | 2017-12-11 | |
| (97) | Date of publication of the European application | 2019-10-16 | 
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 | 
| (46) | Date of publication of the claims translation | 
| (86) | Number | PCT/EP2017/082289 | 
| Date | 2017-12-11 | 
| (87) | Number | WO 2018/104560 | 
| Date | 2018-06-14 | 
| (30) | Number | Date | Country code | 
| PA201600756 | 2016-12-09 | DK | 
| (72) | 
                    
                    
                    
                    
                    DUE LARSEN, Bjarne, DK  
                    
                    
                    
                    
                    GIEHM, Lise, DK  
                    
                    
                    
                    
                    EDWARDS, Alistair Vincent Gordon, DK  | 
| (73) | Zealand Pharma A/S,
                Sydmarken 11, 2860 S borg,
                DK | 
| (54) | GLP-1/GLP-2 DUAL AGONISTS | 
| GLP-1/GLP-2 DUAL AGONISTS |